Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

Published:2012-03-13 Issue:5 Volume:21 Page:524-534
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Toh Sengwee¹,Li Lingling¹,Harrold Leslie R.²,Bayliss Elizabeth A.³⁴,Curtis Jeffrey R.⁵,Liu Liyan⁶,Chen Lang⁵,Grijalva Carlos G.⁷,Herrinton Lisa J.⁶

Affiliation:

1. Department of Population Medicine; Harvard Medical School and Harvard Pilgrim Health Care Institute; Boston MA USA

2. Meyers Primary Care Institute and University of Massachusetts Medical School; Worcester MA USA

3. Institute for Health Research; Kaiser Permanente Colorado; Denver CO USA

4. Department of Family Medicine; University of Colorado School of Medicine; Aurora CO USA

5. Division of Clinical Immunology and Rheumatology; University of Alabama at Birmingham; Birmingham AL USA

6. Division of Research; Kaiser Permanente Northern California; Oakland CA USA

7. Department of Preventive Medicine; Vanderbilt University School of Medicine; Nashville TN USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3238/fullpdf

Reference41 articles.

1. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group;Maini;Lancet,1999

2. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group;Lipsky;N Engl J Med,2000

3. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial;Moreland;Ann Intern Med,1999

4. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes;Genovese;Arthritis Rheum,2002

5. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial;Keystone;Arthritis Rheum,2004

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of biological and targeted synthetic basic anti-inflammatory drugs in elderly patients with rheumatoid arthritis: for or against;Problems of Geroscience;2024-06-30

2. Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study;RMD Open;2023-08

3. Cytokine responses in nonlesional psoriatic skin as clinical predictor to anti-TNF agents;Journal of Allergy and Clinical Immunology;2022-02

4. Features of inflammatory rheumatic diseases treatment in older people;Russian Journal of Geriatric Medicine;2021-10-15

5. Current and recommended practices for evaluating adverse drug events using electronic health records: A systematic review;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2021-10-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3